Obstruction of the outlet of the apocrine duct adjacent to the skin surface, with subsequent rupture into the intradermal plane, initiates the inflammatory condition termed "hidradenitis suppurativa." The chronic manifestations of the process, indicated by recurrent abscess formation, draining sinuses, skin fistulas, and an intense cicatricial response, usually affect the distal two thirds of the anatomic anal canal because the proximal portion is devoid of hair follicles and accessory glands. An anal fistula that lacks continuity with the cryptoglandular units of the dentate margin or intersphincteric space (or both) is suggestive of the presence of hidradenitis. The fistula of chronic hidradenitis suppurativa can be diagnosed by a track that originates in a pitlike scar, usually epithelialized, within the skin of the distal anal canal, which then progresses beyond the anal verge superficial to the internal sphincter muscle. A group of 30 patients have been followed up from one to seven years and are without evidence of recurrent symptoms in the anal canal.
A group of 86 patients with anorectal Crohn's disease were followed up from ten to 40 years to determine the course of the disease and the number of patients who later required proctectomy. The overall cumulative probability of avoiding proctectomy was 91.6 percent at ten years and 82.5 percent at 20 years. Resection of all proximal Crohn's disease did not ameliorate the anorectal disease, except in patients who had all proximal disease removed and had no recurrence.
In an attempt to define the optimal interval of safety when a barium enema study of the colon follows a planned injury of the bowel by local treatment or biopsy (or both), we studied a group of 833 patients who were seen at the Mayo Clinic during 1978. In the study group, 886 polyps were destroyed by fulguration, 258 lesions were both sampled and fulgurated, and 126 areas were sampled for biopsy study. One hundred ninety-four patients had multiple lesions; in 193 of these, 2-18 diminutive polyps were fulgurated. Of the 846 barium studies in the 833 patients, 5 were done on the same day as the planned injury, 543 within 24 hours, and 174 within 72 hours. Four patients demonstrated extravasation of barium, but none had signs or symptoms of acute perforation nor did the resected surgical specimen demonstrate communication with site of injury.
Rectourinary fistula is an uncommon entity with many causes for which the optimal management remains unclear. To clarify this, a 50-year experience with acquired rectourinary fistula at the Mayo Clinic was reviewed. In the management of 57 patients, 34 patients underwent repair of rectourinary fistula, the success rate being 88 per cent and the morbidity 29 per cent. Based on this experience, a simple plan of management emphasizing etiologic and prognostic factors is presented. Repair of rectourinary fistulas can be undertaken with a high degree of success and acceptable morbidity for patients with fistulas of benign cause and for those with fistulas of malignant cause who have no gross evidence of malignancy, minimal induration from irradiation, and anticipated long-term survival. Colostomy as an adjunctive procedure is usually unnecessary in the repair of fistulas associated with benign conditions.
As illustrated by this case report, tetanus can occur as a complication of anorectal surgical procedures or abscesses just as it can in other wounds. A synergistic infection of the perineum occurred in a 62-year-old man 8 days after drainage of an anorectal abscess. He was treated with vigorous debridement and antibiotics and was given tetanus prophylaxis. The next day, tetanus developed, presumably from the original abscess. The patient recovered after aggressive therapy, including muscle relaxants and ventilatory support.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.